1. Home
  2. PLAB vs PHAR Comparison

PLAB vs PHAR Comparison

Compare PLAB & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLAB
  • PHAR
  • Stock Information
  • Founded
  • PLAB 1969
  • PHAR 1988
  • Country
  • PLAB United States
  • PHAR Netherlands
  • Employees
  • PLAB N/A
  • PHAR N/A
  • Industry
  • PLAB Semiconductors
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLAB Technology
  • PHAR Health Care
  • Exchange
  • PLAB Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • PLAB 1.2B
  • PHAR 1.0B
  • IPO Year
  • PLAB 1987
  • PHAR N/A
  • Fundamental
  • Price
  • PLAB $22.64
  • PHAR $15.26
  • Analyst Decision
  • PLAB Strong Buy
  • PHAR Strong Buy
  • Analyst Count
  • PLAB 2
  • PHAR 3
  • Target Price
  • PLAB $31.00
  • PHAR $30.00
  • AVG Volume (30 Days)
  • PLAB 665.2K
  • PHAR 12.0K
  • Earning Date
  • PLAB 08-27-2025
  • PHAR 10-23-2025
  • Dividend Yield
  • PLAB N/A
  • PHAR N/A
  • EPS Growth
  • PLAB N/A
  • PHAR N/A
  • EPS
  • PLAB 1.77
  • PHAR N/A
  • Revenue
  • PLAB $856,152,000.00
  • PHAR $339,836,000.00
  • Revenue This Year
  • PLAB N/A
  • PHAR $16.63
  • Revenue Next Year
  • PLAB $5.06
  • PHAR $6.77
  • P/E Ratio
  • PLAB $12.75
  • PHAR N/A
  • Revenue Growth
  • PLAB N/A
  • PHAR 22.44
  • 52 Week Low
  • PLAB $16.46
  • PHAR $6.73
  • 52 Week High
  • PLAB $31.60
  • PHAR $17.08
  • Technical
  • Relative Strength Index (RSI)
  • PLAB 59.11
  • PHAR 67.22
  • Support Level
  • PLAB $21.44
  • PHAR $13.60
  • Resistance Level
  • PLAB $24.97
  • PHAR $15.40
  • Average True Range (ATR)
  • PLAB 0.80
  • PHAR 0.75
  • MACD
  • PLAB -0.00
  • PHAR 0.14
  • Stochastic Oscillator
  • PLAB 48.68
  • PHAR 90.61

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: